Persistence and adherence to dutasteride/tamsulosin fixed-dose versus free-combination alpha blocker/5ARI therapy in patients with benign prostate hyperplasia in Germany-Reference-Cited by-同舟云学术

Persistence and adherence to dutasteride/tamsulosin fixed-dose versus free-combination alpha blocker/5ARI therapy in patients with benign prostate hyperplasia in Germany

Published:2020-01-01 Issue:01 Volume:58 Page:37-49
ISSN:0946-1965
Container-title:Int. Journal of Clinical Pharmacology and Therapeutics
language:en
Short-container-title:CP

Author:

Eisen Christoph,Lulic Zrinka,Palacios-Moreno Juan Manuel,Adalig Burkay,Hennig Michael,Cortes Vanessa,Gilg Florian,Kostev Karel

Publisher

Dustri-Verlgag Dr. Karl Feistle

Subject

Pharmacology (medical),Pharmacology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx);Cardiology and Therapy;2024-04-13

2. Treatment Patterns and Negative Health Outcomes in Palmoplantar Pustulosis Patients in Germany and the US;Dermatology and Therapy;2024-03

3. German longitudinal prescription database (LRx): Description of characteristics, use in pharmacoepidemiological research, and limitations;Int. Journal of Clinical Pharmacology and Therapeutics;2024-01-01

4. Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial;The Lancet Regional Health - Europe;2023-08

5. Persistence with first-line antihypertensive therapy in Germany: A retrospective cohort study with 2,801,469 patients;Int. Journal of Clinical Pharmacology and Therapeutics;2023-05-01